Prostate Cancer Research Urges UK To Implement Screening Program Without Delay
National Screening Committee Should Not Wait On Transform Trial
Implementing a reflex test alongside traditional prostate cancer screening is cost-effective for high-risk groups, claims Prostate Cancer Research UK. Oxford BioDynamics sheds light on UK market conditions influencing the adoption of its reflex test, EpiSwitch PSE.
